Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line
- 1 November 2001
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 90 (11), 1829-1837
- https://doi.org/10.1002/jps.1133
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Efficacy, Tolerance, and Pharmacokinetics of the Combination of Stavudine, Nevirapine, Nelfinavir, and Saquinavir as Salvage Regimen after Ritonavir or Indinavir FailureAIDS Research and Human Retroviruses, 2001
- Inhibitory Effect of Human Immunodeficiency Virus Protease Inhibitors on Multidrug Resistance Transporter P-Glycoproteins.Biological & Pharmaceutical Bulletin, 2000
- Ritonavir and saquinavir combination therapy for the treatment of HIV infectionAIDS, 1999
- Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroidsInternational Journal of Cancer, 1998
- In Vitro Blood–Brain Barrier Permeability of Nevirapine Compared to Other HIV Antiretroviral AgentsJournal of Pharmaceutical Sciences, 1998
- HIV-1 Protease Inhibitors Are Substrates for theMDR1 Multidrug TransporterBiochemistry, 1998
- Expression of Multidrug Resistance-Associated Protein (MRP) in Brain Microvessel Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.JCI Insight, 1998
- RitonavirClinical Pharmacokinetics, 1998
- Interaction of drugs with P-glycoprotein in brain capillariesBiochemical Pharmacology, 1995